Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Veradermics, Incorporated (MANE)
USD111.16
+0.98 (+0.89%)
US NYSE Healthcare Biotechnology
Address
470 James Street 6513
New Haven, CT, US
New Haven, CT, US
CEO
Reid Waldman
Website
veradermics.com
IPO
2026-02-04
CIK 1827635 ISIN US9229671048
Description
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL. Furthermore, Veradermics is progressing with VDMN, an innovative dissolvable microarray patch technology employing immunotherapy for common warts. Its research also extends to VDAA for addressing alopecia areata, and VDMC, aimed at molluscum contagiosum. Collectively, the firm's product candidates target conditions such as androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. Veradermics caters to healthcare practitioners and clinicians specializing in dermatologic and aesthetic care for patients of all ages, in addition to the wider medical and scientific community engaged in dermatology. Founded in 2019, the company is based in New Haven, Connecticut.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD111.16
+0.98 (+0.89%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
660.8K
Beta
0.77
Float Shares
35.08M
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.91% | -1.30% | +1.93% | +120.09% | +167.31% | +167.31% | +167.31% | +167.31% | +167.31% | +167.31% | +167.31% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Buy
Price Targets & DCF
Current price
111.16
Low
75.00
-32.5%
Consensus
75.00
-32.5%
Median
75.00
-32.5%
High
75.00
-32.5%
DCF (Unlevered)
0.60
-99.5%
DCF (Levered)
0.62
-99.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
75.00
-32.5%
|
| Last Year | 1 |
75.00
-32.5%
|
| All Time | 1 |
75.00
-32.5%
|
Quality scores
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-1,600.0%
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: -11,152.9%
-
Share dilution Biotechnology: -3.4%-82.6% ★
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00×
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2025 actual |
Dec 2026 1 EPS Ana. |
Dec 2027 4 Rev. Ana. 1 EPS Ana. |
Dec 2028 4 Rev. Ana. 2 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
—
|
—
— – —
|
12.99M
12.99M – 12.99M
|
126.27M
121.37M – 131.17M
+872.3% YoY
|
236.05M
236.05M – 236.05M
+86.9% YoY
|
535.10M
535.10M – 535.10M
+126.7% YoY
|
| EBITDA |
-70.00M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-70.00M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-70.00M
est: -236.84M (+70.4%)
|
-108.13M
-112.23M – -94.53M
+54.3% YoY
|
-90.45M
-90.45M – -90.45M
+16.4% YoY
|
-47.56M
-56.59M – -38.53M
+47.4% YoY
|
13.33M
13.33M – 13.33M
+128.0% YoY
|
195.03M
195.03M – 195.03M
+1,363.2% YoY
|
| SGA |
10.28M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-2.38
est: -6.75 (+64.8%)
|
-2.95
-3.20 – -2.69
+56.4% YoY
|
-2.58
-2.58 – -2.58
+12.5% YoY
|
-1.36
-1.61 – -1.10
+47.4% YoY
|
0.38
0.38 – 0.38
+128.0% YoY
|
5.56
5.56 – 5.56
+1,363.2% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-18 | Citigroup | Buy | Buy | Maintain |
| 2026-04-22 | Leerink Partners | Outperform | Outperform | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
81
Total invested
1.63B
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
81
+81 vs prev Q
New positions
81
Closed positions
0
Increased
81
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | 4.17M +4.2M (+100.0%) | 263.27M +263.3M (+100.0%) | 2.07% +2.071 pp | 6.72% +6.724 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 2 | SR ONE CAPITAL MANAGEMENT, LP | 2.40M +2.4M (+100.0%) | 151.68M +151.7M (+100.0%) | 1.19% +1.193 pp | 16.57% +16.569 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 3 | CITADEL ADVISORS LLC | 1.83M +1.8M (+100.0%) | 115.29M +115.3M (+100.0%) | 0.91% +0.907 pp | 0.02% +0.019 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 4 | FMR LLC | 1.79M +1.8M (+100.0%) | 113.22M +113.2M (+100.0%) | 0.89% +0.891 pp | 0.01% +0.006 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 5 | VIKING GLOBAL INVESTORS LP | 1.69M +1.7M (+100.0%) | 106.76M +106.8M (+100.0%) | 0.84% +0.840 pp | 0.30% +0.299 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 6 | SIREN, L.L.C. | 1.51M +1.5M (+100.0%) | 95.06M +95.1M (+100.0%) | 0.75% +0.748 pp | 2.64% +2.635 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 7 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.10M +1.1M (+100.0%) | 69.47M +69.5M (+100.0%) | 0.55% +0.546 pp | 0.11% +0.107 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 8 | ABRDN PLC | 1.05M +1.1M (+100.0%) | 66.60M +66.6M (+100.0%) | 0.52% +0.524 pp | 0.11% +0.108 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 9 | JPMORGAN CHASE & CO | 976.2K +976.2K (+100.0%) | 59.40M +59.4M (+100.0%) | 0.48% +0.485 pp | 0.00% +0.004 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 10 | INFINITUM ASSET MANAGEMENT, LLC | 731.1K +731.1K (+100.0%) | 46.17M +46.2M (+100.0%) | 0.36% +0.363 pp | 5.77% +5.766 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 11 | MARSHALL WACE, LLP | 654.6K +654.6K (+100.0%) | 41.34M +41.3M (+100.0%) | 0.33% +0.325 pp | 0.04% +0.041 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 12 | BALYASNY ASSET MANAGEMENT L.P. | 532.9K +532.9K (+100.0%) | 33.65M +33.7M (+100.0%) | 0.26% +0.265 pp | 0.04% +0.044 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 13 | PARADIGM BIOCAPITAL ADVISORS LP | 525.0K +525.0K (+100.0%) | 33.15M +33.2M (+100.0%) | 0.26% +0.261 pp | 0.68% +0.677 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 14 | AMERIPRISE FINANCIAL INC | 514.0K +514.0K (+100.0%) | 32.46M +32.5M (+100.0%) | 0.26% +0.255 pp | 0.01% +0.008 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 15 | WOODLINE PARTNERS LP | 500.6K +500.6K (+100.0%) | 31.62M +31.6M (+100.0%) | 0.25% +0.249 pp | 0.12% +0.120 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 16 | DEEP TRACK CAPITAL, LP | 500.0K +500.0K (+100.0%) | 31.58M +31.6M (+100.0%) | 0.25% +0.248 pp | 0.52% +0.516 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 17 | WELLINGTON MANAGEMENT GROUP LLP | 477.8K +477.8K (+100.0%) | 30.18M +30.2M (+100.0%) | 0.24% +0.237 pp | 0.01% +0.006 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 18 | UBS GROUP AG | 347.1K +347.1K (+100.0%) | 21.92M +21.9M (+100.0%) | 0.17% +0.172 pp | 0.00% +0.003 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 19 | VIVO CAPITAL, LLC | 300.0K +300.0K (+100.0%) | 18.95M +18.9M (+100.0%) | 0.15% +0.149 pp | 1.57% +1.575 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 20 | STIFEL FINANCIAL CORP | 294.1K +294.1K (+100.0%) | 18.57M +18.6M (+100.0%) | 0.15% +0.146 pp | 0.02% +0.017 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 21 | BLACKROCK, INC. | 282.6K +282.6K (+100.0%) | 17.85M +17.8M (+100.0%) | 0.14% +0.140 pp | 0.00% +0.000 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 22 | FRANKLIN RESOURCES INC | 200.0K +200.0K (+100.0%) | 12.63M +12.6M (+100.0%) | 0.10% +0.099 pp | 0.00% +0.003 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 23 | GEODE CAPITAL MANAGEMENT, LLC | 178.2K +178.2K (+100.0%) | 11.26M +11.3M (+100.0%) | 0.09% +0.089 pp | 0.00% +0.001 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 24 | CATALIO CAPITAL MANAGEMENT, LP | 173.6K +173.6K (+100.0%) | 10.96M +11.0M (+100.0%) | 0.09% +0.086 pp | 2.29% +2.290 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 25 | GOLDMAN SACHS GROUP INC | 169.0K +169.0K (+100.0%) | 10.67M +10.7M (+100.0%) | 0.08% +0.084 pp | 0.00% +0.001 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 26 | ENSIGN PEAK ADVISORS, INC | 150.0K +150.0K (+100.0%) | 9.47M +9.5M (+100.0%) | 0.07% +0.075 pp | 0.02% +0.018 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 27 | — | 145.7K +145.7K (+100.0%) | 9.20M +9.2M (+100.0%) | 0.07% +0.072 pp | 6.51% +6.509 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 28 | JENNISON ASSOCIATES LLC | 141.8K +141.8K (+100.0%) | 8.95M +9.0M (+100.0%) | 0.07% +0.070 pp | 0.01% +0.006 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 29 | D. E. SHAW & CO., INC. | 134.2K +134.2K (+100.0%) | 8.48M +8.5M (+100.0%) | 0.07% +0.067 pp | 0.01% +0.005 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 30 | EMERALD ADVISERS, LLC | 132.5K +132.5K (+100.0%) | 8.37M +8.4M (+100.0%) | 0.07% +0.066 pp | 0.26% +0.265 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 31 | MILLENNIUM MANAGEMENT LLC | 123.2K +123.2K (+100.0%) | 7.78M +7.8M (+100.0%) | 0.06% +0.061 pp | 0.00% +0.003 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 32 | MYDA ADVISORS LLC | 120.0K +120.0K (+100.0%) | 7.58M +7.6M (+100.0%) | 0.06% +0.060 pp | 1.25% +1.247 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 33 | EMERALD MUTUAL FUND ADVISERS TRUST | 109.3K +109.3K (+100.0%) | 6.90M +6.9M (+100.0%) | 0.05% +0.054 pp | 0.33% +0.335 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 34 | MASTERS CAPITAL MANAGEMENT LLC | 100.0K +100.0K (+100.0%) | 6.32M +6.3M (+100.0%) | 0.05% +0.050 pp | 0.21% +0.209 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 35 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 98.0K +98.0K (+100.0%) | 6.19M +6.2M (+100.0%) | 0.05% +0.049 pp | 0.00% +0.001 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 36 | VANGUARD FIDUCIARY TRUST CO | 98.0K +98.0K (+100.0%) | 6.19M +6.2M (+100.0%) | 0.05% +0.049 pp | 0.00% +0.002 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 37 | SEVEN GRAND MANAGERS, LLC | 74.8K +74.8K (+100.0%) | 4.72M +4.7M (+100.0%) | 0.04% +0.037 pp | 0.32% +0.315 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 38 | STATE STREET CORP | 74.4K +74.4K (+100.0%) | 4.70M +4.7M (+100.0%) | 0.04% +0.037 pp | 0.00% +0.000 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 39 | SOFINNOVA INVESTMENTS, INC. | 73.3K +73.3K (+100.0%) | 4.63M +4.6M (+100.0%) | 0.04% +0.036 pp | 0.18% +0.176 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 40 | AFFINITY ASSET ADVISORS, LLC | 70.0K +70.0K (+100.0%) | 4.42M +4.4M (+100.0%) | 0.03% +0.035 pp | 0.23% +0.228 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 41 | BANK OF AMERICA CORP /DE/ | 65.7K +65.7K (+100.0%) | 4.15M +4.1M (+100.0%) | 0.03% +0.033 pp | 0.00% +0.000 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 42 | BAMCO INC /NY/ | 59.7K +59.7K (+100.0%) | 3.77M +3.8M (+100.0%) | 0.03% +0.030 pp | 0.01% +0.011 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 43 | MORGAN STANLEY | 51.7K +51.7K (+100.0%) | 3.26M +3.3M (+100.0%) | 0.03% +0.026 pp | 0.00% +0.000 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 44 | MONASHEE INVESTMENT MANAGEMENT LLC | 50.0K +50.0K (+100.0%) | 3.16M +3.2M (+100.0%) | 0.02% +0.025 pp | 1.72% +1.718 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 45 | POLYMER CAPITAL MANAGEMENT (HK) LTD | 41.3K +41.3K (+100.0%) | 2.61M +2.6M (+100.0%) | 0.02% +0.021 pp | 0.23% +0.225 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 46 | BARCLAYS PLC | 36.9K +36.9K (+100.0%) | 2.33M +2.3M (+100.0%) | 0.02% +0.018 pp | 0.00% +0.001 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 47 | NORTHERN TRUST CORP | 34.5K +34.5K (+100.0%) | 2.18M +2.2M (+100.0%) | 0.02% +0.017 pp | 0.00% +0.000 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 48 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 30.1K +30.1K (+100.0%) | 1.90M +1.9M (+100.0%) | 0.01% +0.015 pp | 0.02% +0.017 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 49 | LOGOS GLOBAL MANAGEMENT LP | 25.0K +25.0K (+100.0%) | 1.58M +1.6M (+100.0%) | 0.01% +0.012 pp | 0.08% +0.079 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 50 | CENTIVA CAPITAL, LP | 20.0K +20.0K (+100.0%) | 1.26M +1.3M (+100.0%) | 0.01% +0.010 pp | 0.01% +0.009 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 51 | FIRST TRUST ADVISORS LP | 19.8K +19.8K (+100.0%) | 1.25M +1.2M (+100.0%) | 0.01% +0.010 pp | 0.00% +0.001 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 52 | SHAY CAPITAL LLC | 18.0K +18.0K (+100.0%) | 1.14M +1.1M (+100.0%) | 0.01% +0.009 pp | 0.09% +0.095 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 53 | SQUAREPOINT OPS LLC | 16.6K +16.6K (+100.0%) | 1.05M +1.0M (+100.0%) | 0.01% +0.008 pp | 0.00% +0.001 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 54 | PENSERRA CAPITAL MANAGEMENT LLC | 14.7K +14.7K (+100.0%) | 928.0K +928.0K (+100.0%) | 0.01% +0.007 pp | 0.01% +0.011 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 55 | FORMULA GROWTH LTD | 14.0K +14.0K (+100.0%) | 884.1K +884.1K (+100.0%) | 0.01% +0.007 pp | 0.40% +0.399 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 56 | TORONTO DOMINION BANK | 13.4K +13.4K (+100.0%) | 848.0K +848.0K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.001 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 57 | XTX TOPCO LTD | 11.5K +11.5K (+100.0%) | 726.9K +726.9K (+100.0%) | 0.01% +0.006 pp | 0.01% +0.013 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 58 | HUDSON BAY CAPITAL MANAGEMENT LP | 11.1K +11.1K (+100.0%) | 699.6K +699.6K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.002 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 59 | CITIGROUP INC | 10.7K +10.7K (+100.0%) | 675.1K +675.1K (+100.0%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 60 | PERSISTENT ASSET PARTNERS LTD | 9.2K +9.2K (+100.0%) | 580.4K +580.4K (+100.0%) | 0.00% +0.005 pp | 0.22% +0.216 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 61 | LEGAL & GENERAL GROUP PLC | 7.1K +7.1K (+100.0%) | 448.7K +448.7K (+100.0%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 62 | VANGUARD GLOBAL ADVISERS, LLC | 6.7K +6.7K (+100.0%) | 426.1K +426.1K (+100.0%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 63 | LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 6.7K +6.7K (+100.0%) | 423.8K +423.8K (+100.0%) | 0.00% +0.003 pp | 0.03% +0.027 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 64 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5.0K +5.0K (+100.0%) | 315.8K +315.8K (+100.0%) | 0.00% +0.003 pp | 0.00% +0.004 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 65 | BURKEHILL GLOBAL MANAGEMENT, LP | 5.0K +5.0K (+100.0%) | 315.8K +315.8K (+100.0%) | 0.00% +0.003 pp | 0.02% +0.016 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 66 | PRIVATE ADVISOR GROUP, LLC | 5.0K +5.0K (+100.0%) | 315.8K +315.8K (+100.0%) | 0.00% +0.003 pp | 0.00% +0.002 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 67 | GHISALLO CAPITAL MANAGEMENT LLC | 5.0K +5.0K (+100.0%) | 315.8K +315.8K (+100.0%) | 0.00% +0.003 pp | 0.01% +0.009 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 68 | SCHONFELD STRATEGIC ADVISORS LLC | 3.9K +3.9K (+100.0%) | 246.3K +246.3K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.002 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 69 | BANK OF NEW YORK MELLON CORP | 3.7K +3.7K (+100.0%) | 231.6K +231.6K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 70 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 3.4K +3.4K (+100.0%) | 212.1K +212.1K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.002 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 71 | US BANCORP \DE\ | 470.00 +470.0 (+100.0%) | 29.7K +29.7K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 72 | ALLWORTH FINANCIAL LP | 50.00 +50.0 (+100.0%) | 3.2K +3.2K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD63.14 +0.0% | 1 qtrs NEW |
| 73 | NVWM, LLC | 35.00 +35.0 (+100.0%) | 2.2K +2.2K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.001 pp | USD63.14 +0.0% | 1 qtrs NEW |
| 74 | SBI SECURITIES CO., LTD. | 20.00 +20.0 (+100.0%) | 1.3K +1.3K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD63.15 +0.0% | 1 qtrs NEW |
| 75 | ROYAL BANK OF CANADA | 8.00 +8.0 (+100.0%) | 1.0K +1.0K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD63.13 +0.0% | 1 qtrs NEW |
| 76 | JONES FINANCIAL COMPANIES LLLP | 10.00 +10.0 (+100.0%) | 655.00 +655.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD63.10 +0.1% | 1 qtrs NEW |
| 77 | TOWER RESEARCH CAPITAL LLC (TRC) | 10.00 +10.0 (+100.0%) | 632.00 +632.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD63.10 +0.1% | 1 qtrs NEW |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
Shares Outstanding
41.78M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Reid Waldman | CEO & Director | 917.4K | — |
| Timothy Durso | Chief Technical Officer | 658.5K | — |
| Dominic Carrano | CFO & Treasurer | 633.3K | male |
| Elizabeth Lindemann | Associate Director of Medical Affairs | — | — |
| Erika Sipperly | Controller | — | female |
| Aron Shapiro | Vice President of Clinical Development & Regulatory Affairs | — | male |
| Mark Neumann | Chief Commercial and Strategy Officer | — | male |
| Michael Murphy | VP of Project & Program Management of Business Technology and Chief of Staff | — | male |
| Michael Smolinski | Vice President of Development & Scientific Operations | — | — |
| Michael V. Greco | General Counsel & Secretary | — | male |
| Karl Pruss | Senior Director of Manufacturing Sciences & Technology | — | male |
| Barbara Szymaszek | Director of Clinical Operations | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MANE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
